Filtered By:
Condition: Patent Foramen Ovale
Management: Medicare
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Cost Effectiveness of Percutaneous Closure Versus Medical Therapy for Cryptogenic Stroke in Patients With a Patent Foramen Ovale
In patients with patent foramen ovales (PFOs) and cryptogenic stroke, observational studies have demonstrated reductions in recurrent neurologic events with transcatheter PFO closure compared with medical therapy. Randomized controlled trials and meta-analyses have shown a trend toward benefit with device closure. The cost-effectiveness of PFO closure has not been described. Therefore, a detailed cost analysis was performed using pooled weighted outcome and complication rates from published randomized controlled trials, Medicare cost tables, and wholesale medication prices.
Source: The American Journal of Cardiology - September 4, 2014 Category: Cardiology Authors: Christopher A. Pickett, Todd C. Villines, Michael A. Ferguson, Edward A. Hulten Tags: Miscellaneous Source Type: research
